02 September 2022 : Clinical Research
Comparative Evaluation of 3 Commercial Mouthwash Formulations on Clinical Parameters of Chronic Gingivitis
Shahabe Saquib Abullais1ABFG, Sabiha Ilyas Patel2ADEF, Elyas Ali Asiri3ABCE, Adel Ali Ahmed Jathmi3ABE, Afnan Hassan Alkhayri3ADEG, Yosra Mohammed Mousa3BEFG, Atheer Abdulhade Ganem4BCE, Khurshid A. Mattoo5CDE*DOI: 10.12659/MSM.937111
Med Sci Monit 2022; 28:e937111
Table 2 Comparative mean scores of clinical parameters among patients in various groups and the respective level of significance between various groups at different intervals of time.
| Clinical parameters | Group 1 (CHX) | Group 2 (Manuka) | Group 3 (ProB) | P-value (Inter-Group) | |||
|---|---|---|---|---|---|---|---|
| Mean±SD | Mean±SD | Mean±SD | Group 1 vs group 2 | Group 1 vs group 3 | Group 2 vs group 3 | ||
| Plaque Index | Baseline | 1.35±0.23 | 1.43±0.21 | 1.31±0.16 | 0.883 | 0.999 | 0.356 |
| Day 7 | 0.73±0.14 | 0.79±0.15 | 0.92±0.16 | 0.840 | 0.004** | 0.078 | |
| Day 14 | 0.69±0.13 | 0.61±0.18 | 0.81±0.15 | 0.399 | 0.155 | 0.003** | |
| Day 28 | 0.66±0.11 | 0.71±0.15 | 0.87±0.13 | 0.999 | 0.001*** | 0.004** | |
| Gingival Index | Baseline | 1.35±0.12 | 1.39±0.19 | 1.41±0.23 | 0.999 | 0.999 | 0.999 |
| Day 7 | 0.75±0.15 | 0.76±0.10 | 0.98±0.15 | 0.999 | 0.001*** | 0.001*** | |
| Day 14 | 0.66±0.20 | 0.57±0.21 | 0.85±0.16 | 0.562 | 0.031* | 0.001*** | |
| Day 28 | 0.61±0.16 | 0.61±0.19 | 0.89±0.14 | 0.999 | 0.001*** | 0.001*** | |
| Bleeding Index | Baseline | 0.93±0.17 | 0.98±0.16 | 1.03±0.17 | 0.999 | 0.330 | 0.999 |
| Day 7 | 0.47±0.17 | 0.45±0.11 | 0.61±0.13 | 0.999 | 0.024* | 0.008** | |
| Day 14 | 0.45±0.17 | 0.33±0.17 | 0.54±0.10 | 0.086 | 0.385 | 0.001*** | |
| Day 28 | 0.46±0.15 | 0.38±0.19=7 | 0.55±0.10 | 0.411 | 0.324 | 0.009** | |
| CHX – chlorhexidine; ProB – probiotics; vs – versus. Levels of significance: NS (not-significant)=P≥0.05; * Significant=P ** Very significant=P *** Highly significant=P | |||||||